You are here

  • Home
  • Archive
  • Volume 6, Issue 12
  • Third-generation CD28/4-1BB chimeric antigen receptor T cells for chemotherapy relapsed or refractory acute lymphoblastic leukaemia: a non-randomised, open-label phase I trial protocol

Citation Tools

Article menu

Download PDFPDF

XML
Haematology (incl blood transfusion)
Protocol
Third-generation CD28/4-1BB chimeric antigen receptor T cells for chemotherapy relapsed or refractory acute lymphoblastic leukaemia: a non-randomised, open-label phase I trial protocol

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Tang X, Sun Y, Zhang A, et al
Third-generation CD28/4-1BB chimeric antigen receptor T cells for chemotherapy relapsed or refractory acute lymphoblastic leukaemia: a non-randomised, open-label phase I trial protocol
BMJ Open 2016;6:e013904. doi: 10.1136/bmjopen-2016-013904